# ARIPIPRAZOLE
> **ANDA215595** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-10-25
## Drug
- **FDA Application Number:** ANDA215595
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ARIPIPRAZOLE
- **Generic name:** ARIPIPRAZOLE
- **Active ingredients:** ARIPIPRAZOLE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL RX
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2022-10-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215595)
---
*AI Analytics · CC0 1.0*